110.07
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVDA?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$111.43
Offen:
$111.485
24-Stunden-Volumen:
101.42M
Relative Volume:
0.40
Marktkapitalisierung:
$2.72T
Einnahmen:
$130.50B
Nettoeinkommen (Verlust:
$72.88B
KGV:
37.46
EPS:
2.938
Netto-Cashflow:
$60.85B
1W Leistung:
-6.50%
1M Leistung:
-11.91%
6M Leistung:
-9.35%
1J Leistung:
+21.79%
Nvidia Corp Stock (NVDA) Company Profile
Firmenname
Nvidia Corp
Sektor
Branche
Telefon
408-486-2000
Adresse
2788 SAN TOMAS EXPRESSWAY, SANTA CLARA, CA
Vergleichen Sie NVDA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
NVDA
Nvidia Corp
|
109.97 | 2.72T | 130.50B | 72.88B | 60.85B | 2.938 |
![]()
TSM
Taiwan Semiconductor Manufacturing Adr
|
165.50 | 939.59B | 90.09B | 36.51B | 26.84B | 7.0399 |
![]()
AVGO
Broadcom Inc
|
169.06 | 807.47B | 54.53B | 10.07B | 20.73B | 2.082 |
![]()
QCOM
Qualcomm Inc
|
153.47 | 174.71B | 40.70B | 10.56B | 12.74B | 9.36 |
![]()
AMD
Advanced Micro Devices Inc
|
103.63 | 171.41B | 25.79B | 1.64B | 2.41B | 0.99 |
Nvidia Corp Stock (NVDA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-02-27 | Herabstufung | Summit Insights | Buy → Hold |
2024-11-21 | Bestätigt | Barclays | Overweight |
2024-11-21 | Bestätigt | Evercore ISI | Outperform |
2024-11-21 | Bestätigt | Goldman | Buy |
2024-11-21 | Bestätigt | JP Morgan | Overweight |
2024-11-21 | Bestätigt | Needham | Buy |
2024-11-21 | Bestätigt | Robert W. Baird | Outperform |
2024-11-21 | Bestätigt | TD Cowen | Buy |
2024-11-21 | Bestätigt | The Benchmark Company | Buy |
2024-11-21 | Bestätigt | Truist | Buy |
2024-11-21 | Bestätigt | Wells Fargo | Overweight |
2024-11-14 | Bestätigt | Oppenheimer | Outperform |
2024-11-12 | Eingeleitet | Redburn Atlantic | Buy |
2024-10-18 | Bestätigt | BofA Securities | Buy |
2024-10-11 | Bestätigt | Goldman | Buy |
2024-09-18 | Eingeleitet | William Blair | Outperform |
2024-08-29 | Bestätigt | Needham | Buy |
2024-08-19 | Bestätigt | Goldman | Buy |
2024-08-06 | Hochstufung | New Street | Neutral → Buy |
2024-07-15 | Bestätigt | TD Cowen | Buy |
2024-07-12 | Bestätigt | The Benchmark Company | Buy |
2024-07-09 | Bestätigt | KeyBanc Capital Markets | Overweight |
2024-07-08 | Bestätigt | UBS | Buy |
2024-07-05 | Herabstufung | New Street | Buy → Neutral |
2024-07-01 | Bestätigt | Morgan Stanley | Overweight |
2024-06-18 | Bestätigt | Rosenblatt | Buy |
2024-06-03 | Bestätigt | BofA Securities | Buy |
2024-05-24 | Herabstufung | DZ Bank | Buy → Hold |
2024-05-23 | Bestätigt | Craig Hallum | Buy |
2024-05-23 | Bestätigt | Deutsche Bank | Hold |
2024-05-23 | Bestätigt | Evercore ISI | Outperform |
2024-05-23 | Bestätigt | Goldman | Buy |
2024-05-23 | Bestätigt | JP Morgan | Overweight |
2024-05-23 | Bestätigt | Jefferies | Buy |
2024-05-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
2024-05-23 | Bestätigt | Mizuho | Buy |
2024-05-23 | Bestätigt | Morgan Stanley | Overweight |
2024-05-23 | Bestätigt | Needham | Buy |
2024-05-23 | Bestätigt | Piper Sandler | Overweight |
2024-05-23 | Bestätigt | Raymond James | Strong Buy |
2024-05-23 | Bestätigt | Stifel | Buy |
2024-05-23 | Bestätigt | Susquehanna | Positive |
2024-05-23 | Bestätigt | TD Cowen | Buy |
2024-05-23 | Bestätigt | The Benchmark Company | Buy |
2024-05-23 | Bestätigt | Truist | Buy |
2024-05-23 | Bestätigt | UBS | Buy |
2024-05-23 | Bestätigt | Wells Fargo | Overweight |
2024-05-23 | Bestätigt | Wolfe Research | Outperform |
2024-05-20 | Bestätigt | Barclays | Overweight |
2024-05-20 | Bestätigt | Robert W. Baird | Outperform |
2024-05-20 | Bestätigt | Stifel | Buy |
2024-05-20 | Bestätigt | Susquehanna | Positive |
2024-05-13 | Eingeleitet | Jefferies | Buy |
2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
2024-04-11 | Bestätigt | Raymond James | Strong Buy |
2024-04-10 | Bestätigt | Morgan Stanley | Overweight |
2024-04-08 | Bestätigt | KeyBanc Capital Markets | Overweight |
2024-03-22 | Bestätigt | UBS | Buy |
2024-03-21 | Bestätigt | TD Cowen | Outperform |
2024-03-07 | Bestätigt | Mizuho | Buy |
2024-02-22 | Bestätigt | BofA Securities | Buy |
2024-02-22 | Bestätigt | Cantor Fitzgerald | Overweight |
2024-02-22 | Bestätigt | Citigroup | Buy |
2024-02-22 | Bestätigt | DA Davidson | Neutral |
2024-02-22 | Bestätigt | Deutsche Bank | Hold |
2024-02-22 | Bestätigt | Goldman | Buy |
2024-02-22 | Bestätigt | HSBC Securities | Buy |
2024-02-22 | Bestätigt | JP Morgan | Overweight |
2024-02-22 | Bestätigt | Jefferies | Buy |
2024-02-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
2024-02-22 | Bestätigt | Mizuho | Buy |
2024-02-22 | Bestätigt | Morgan Stanley | Overweight |
2024-02-22 | Bestätigt | Needham | Buy |
2024-02-22 | Bestätigt | Stifel | Buy |
2024-02-22 | Bestätigt | TD Cowen | Outperform |
2024-02-22 | Bestätigt | The Benchmark Company | Buy |
2024-02-22 | Bestätigt | Truist | Buy |
2024-02-22 | Bestätigt | UBS | Buy |
2024-02-22 | Bestätigt | Wedbush | Outperform |
2024-02-22 | Bestätigt | Wolfe Research | Outperform |
2024-02-16 | Eingeleitet | Loop Capital | Buy |
2024-02-15 | Bestätigt | Piper Sandler | Overweight |
2024-02-13 | Bestätigt | UBS | Buy |
2024-02-05 | Bestätigt | Goldman | Buy |
2024-01-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
2024-01-03 | Eingeleitet | DA Davidson | Neutral |
2023-11-22 | Bestätigt | BMO Capital Markets | Outperform |
2023-11-22 | Bestätigt | Bernstein | Outperform |
2023-11-22 | Bestätigt | BofA Securities | Buy |
2023-11-22 | Herabstufung | Edward Jones | Buy → Hold |
2023-11-22 | Bestätigt | Goldman | Buy |
2023-11-22 | Bestätigt | JP Morgan | Overweight |
2023-11-22 | Bestätigt | Mizuho | Buy |
2023-11-22 | Bestätigt | Morgan Stanley | Overweight |
2023-11-22 | Bestätigt | Rosenblatt | Buy |
2023-11-22 | Bestätigt | Truist | Buy |
2023-11-22 | Bestätigt | UBS | Buy |
2023-11-22 | Bestätigt | Wells Fargo | Overweight |
2023-10-11 | Bestätigt | TD Cowen | Outperform |
2023-08-24 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
2023-08-24 | Bestätigt | Rosenblatt | Buy |
2023-08-24 | Hochstufung | Stifel | Hold → Buy |
2023-08-24 | Bestätigt | TD Cowen | Outperform |
2023-08-21 | Bestätigt | HSBC Securities | Buy |
2023-08-21 | Bestätigt | KeyBanc Capital Markets | Overweight |
2023-08-09 | Bestätigt | Stifel | Hold |
2023-07-24 | Bestätigt | Mizuho | Buy |
2023-07-20 | Eingeleitet | Wolfe Research | Outperform |
2023-07-17 | Bestätigt | Citigroup | Buy |
2023-07-14 | Bestätigt | Truist | Buy |
2023-07-11 | Bestätigt | KeyBanc Capital Markets | Overweight |
2023-06-30 | Hochstufung | Daiwa Securities | Neutral → Outperform |
2023-06-16 | Bestätigt | Morgan Stanley | Overweight |
2023-05-25 | Hochstufung | Craig Hallum | Hold → Buy |
2023-05-25 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2023-05-25 | Hochstufung | Wedbush | Neutral → Outperform |
2023-04-19 | Bestätigt | BofA Securities | Buy |
2023-04-18 | Hochstufung | HSBC Securities | Reduce → Buy |
2023-03-27 | Bestätigt | UBS | Buy |
2023-03-21 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
2023-03-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2023-03-02 | Fortgesetzt | Raymond James | Strong Buy |
2023-02-23 | Hochstufung | Goldman | Neutral → Buy |
2023-02-21 | Bestätigt | BMO Capital Markets | Outperform |
2023-02-16 | Herabstufung | DZ Bank | Buy → Sell |
2023-01-23 | Bestätigt | Truist | Buy |
2022-12-19 | Bestätigt | Needham | Buy |
2022-12-15 | Eingeleitet | HSBC Securities | Reduce |
2022-11-17 | Hochstufung | Summit Insights | Hold → Buy |
2022-11-16 | Fortgesetzt | Credit Suisse | Outperform |
2022-09-08 | Eingeleitet | Stifel | Hold |
2022-09-02 | Herabstufung | Daiwa Securities | Outperform → Neutral |
2022-08-08 | Herabstufung | Craig Hallum | Buy → Hold |
2022-07-13 | Bestätigt | Susquehanna | Positive |
2022-05-26 | Fortgesetzt | The Benchmark Company | Buy |
2022-05-03 | Fortgesetzt | Morgan Stanley | Equal-Weight |
2022-04-13 | Hochstufung | New Street | Neutral → Buy |
2022-04-11 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2022-03-15 | Bestätigt | Cowen | Outperform |
2022-03-07 | Fortgesetzt | Goldman | Neutral |
2022-02-17 | Herabstufung | Summit Insights | Buy → Hold |
2021-11-18 | Bestätigt | BofA Securities | Buy |
2021-11-18 | Bestätigt | Craig Hallum | Buy |
2021-11-18 | Bestätigt | Deutsche Bank | Hold |
2021-11-18 | Bestätigt | JP Morgan | Overweight |
2021-11-18 | Bestätigt | Jefferies | Buy |
2021-11-18 | Bestätigt | KeyBanc Capital Markets | Overweight |
2021-11-18 | Bestätigt | Mizuho | Buy |
2021-11-18 | Bestätigt | Needham | Buy |
2021-11-18 | Bestätigt | Piper Sandler | Overweight |
2021-11-18 | Bestätigt | Raymond James | Strong Buy |
2021-11-18 | Bestätigt | Truist | Buy |
2021-11-15 | Bestätigt | Citigroup | Buy |
2021-11-15 | Bestätigt | UBS | Buy |
2021-11-12 | Herabstufung | Wedbush | Outperform → Neutral |
2021-10-22 | Hochstufung | Summit Insights | Sell → Buy |
2021-10-05 | Bestätigt | KeyBanc Capital Markets | Overweight |
2021-09-17 | Bestätigt | BofA Securities | Buy |
2021-08-20 | Fortgesetzt | The Benchmark Company | Buy |
2021-08-19 | Herabstufung | Summit Insights | Hold → Sell |
2021-08-12 | Bestätigt | Evercore ISI | Outperform |
2021-08-12 | Bestätigt | UBS | Buy |
2021-08-12 | Bestätigt | Wells Fargo | Overweight |
2021-08-04 | Bestätigt | Rosenblatt | Buy |
2021-07-15 | Bestätigt | Mizuho | Buy |
2021-07-08 | Bestätigt | Oppenheimer | Outperform |
2021-07-06 | Bestätigt | KeyBanc Capital Markets | Overweight |
2021-07-01 | Bestätigt | BMO Capital Markets | Outperform |
2021-06-22 | Bestätigt | Raymond James | Strong Buy |
2021-06-18 | Bestätigt | BofA Securities | Buy |
2021-06-17 | Bestätigt | Jefferies | Buy |
2021-05-27 | Bestätigt | BofA Securities | Buy |
2021-05-27 | Bestätigt | Cowen | Outperform |
2021-05-27 | Hochstufung | Craig Hallum | Hold → Buy |
2021-05-20 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
2021-05-05 | Eingeleitet | Robert W. Baird | Outperform |
2021-04-15 | Hochstufung | Raymond James | Outperform → Strong Buy |
2021-04-13 | Bestätigt | Cowen | Outperform |
2021-04-13 | Bestätigt | Rosenblatt | Buy |
2021-02-25 | Bestätigt | Cowen | Outperform |
2021-02-22 | Bestätigt | Susquehanna | Positive |
2021-02-03 | Hochstufung | New Street | Sell → Neutral |
2020-11-12 | Bestätigt | Cascend Securities | Buy |
2020-10-09 | Herabstufung | New Street | Neutral → Sell |
2020-10-06 | Bestätigt | BMO Capital Markets | Outperform |
2020-10-02 | Bestätigt | Wedbush | Outperform |
2020-09-15 | Bestätigt | Needham | Buy |
2020-09-02 | Bestätigt | BofA Securities | Buy |
2020-09-02 | Bestätigt | Credit Suisse | Outperform |
2020-09-02 | Bestätigt | Goldman | Buy |
2020-09-02 | Bestätigt | Mizuho | Buy |
2020-09-02 | Bestätigt | RBC Capital Mkts | Outperform |
2020-09-02 | Bestätigt | The Benchmark Company | Buy |
2020-08-20 | Bestätigt | Morgan Stanley | Equal-Weight |
2020-08-20 | Bestätigt | Needham | Buy |
2020-08-20 | Bestätigt | RBC Capital Mkts | Outperform |
2020-08-20 | Bestätigt | Raymond James | Outperform |
2020-08-20 | Bestätigt | Rosenblatt | Buy |
2020-08-20 | Bestätigt | Susquehanna | Positive |
2020-08-20 | Bestätigt | Truist | Buy |
2020-08-20 | Bestätigt | Wedbush | Outperform |
2020-08-20 | Bestätigt | Wells Fargo | Overweight |
Alle ansehen
Nvidia Corp Aktie (NVDA) Neueste Nachrichten
A Nvidia chip shortage is coming, warns major Chinese server maker - Fast Company
Nvidia-backed CoreWeave's shares likely to open up to 25% above IPO price - Marketscreener.com
Nvidia-Backed CoreWeave Prices IPO at $40 Per Share, Lower Than Earlier Estimate - Yahoo Finance
NVIDIA Corporation (NVDA) Gets Bullish Nod From Melius – Here’s Why the Cisco Deal Matters - MSN
Better Artificial Intelligence Stock: AMD vs. Nvidia - Nasdaq
Nvidia Stock Gains. Why Trump and China Are Key to AI Chip Maker’s Recovery. - Barron's
Nvidia Stock Is Down Over 20% From Its All-Time High. Here's Why It Could Soar by the End of 2025. - Yahoo Finance
Exclusive: China's H3C warns of Nvidia AI chip shortage amid surging demand - Reuters
Nvidia’s Huang Offers Some Practical Advice for Quantum Industry Leaders - Bloomberg
Nvidia Stock Investors Can Be Reasonably Confident in the Company's Competitive Advantages - Nasdaq
Intel's SuperFluid Cooling Tech 'Possibly Suitable For Nvidia's GB300' Chips, Says Expert Amid INTC's Efforts To Secure Commitments For Foundry Services - Benzinga
Hyperscale Data Completes First Installation of Nvidia GPUs for HPC Customer - GlobeNewswire
Where Will Nvidia Stock Be in 4 Years? The Answer May Shock You. - Nasdaq
Should I buy Nvidia stock for my ISA at $111? - Yahoo Finance UK
CoreWeave Prices IPO at $40 per Share - Marketscreener.com
China Server Maker H3C Running Short of Nvidia Chips - Marketscreener.com
Variant Private Wealth LLC Takes $2.09 Million Position in NVIDIA Co. (NASDAQ:NVDA) - MarketBeat
NVIDIA Co. (NASDAQ:NVDA) Position Raised by Peregrine Asset Advisers Inc. - MarketBeat
CoreWeave IPO: Nvidia-Backed Data Center Company Prices IPO Below Earlier Range But Retail Calls It Fair - MSN
[News] Intel’s Comeback? NVIDIA and Broadcom Reportedly Eye 18A, with a Boosted Version in the Works - TrendForce
Nvidia-backed CoreWeave downsizes US IPO - Reuters
Nvidia-Backed CoreWeave Prices Its IPO at $40 Per Share, Below Expectations - Investopedia
Nvidia-backed CoreWeave prices downsized US IPO at $40 per share - Marketscreener.com
Is NVIDIA Corporation (NVDA) the Top Blue Chip AI Stock to Buy According to Billionaire Cliff Asness? - Insider Monkey
Why May 15 is a key date to watch for Nvidia stock - Yahoo
Veteran fund manager offers blunt take after Nvidia stock drop - TheStreet
AMD Vs. Nvidia: Which AI Chip Stock Should You Buy On The Dip? - Barchart
Nvidia-backed CoreWeave slashes IPO size and price amid investor concerns - Fast Company
Morgan Stanley: NVIDIA (NVDA)’s GTC Proves Why AI Market Scepticism Is Misguided - Insider Monkey
In Geopolitical Chess, China's Latest Energy Norms Block Nvidia's Chip Strategy Amid US Sanctions - Yahoo Finance
Should You Buy, Sell, Or Hold Nvidia Stock On Gretel Acquisition News? - Barchart
Report: Nvidia close to acquiring AI cloud provider Lepton AI in nine-figure deal - SiliconANGLE News
Not A No. 2 To Nvidia: Initiating AMD With A Strong Buy (NASDAQ:AMD) - Seeking Alpha
Death Cross Pattern Appears for NVIDIA Stock: Buy, Hold, or Sell? - Nasdaq
AI reality bytes Nvidia-backed CoreWeave IPO - TheStreet
Nvidia-Backed CoreWeave Lowers IPO Target Amid Debt Load and Investor Skepticism - Yahoo Canada Finance
Intel’s New CEO Vows to Compete with Nvidia’s Best AI Server - Barron's
Sector Update: Tech Stocks Fall Thursday Afternoon - Marketscreener.com
Nvidia Stock Is Falling on Threats of More Restrictions in China. How Should You Play NVDA Here? - Barchart
Nvidia seen stepping in to prop up CoreWeave's struggling IPO - Yahoo Finance
Nvidia-Backed CoreWeave IPO: 5 Things Investors Need To Know Before Buying SharesMicrosoft (NASDAQ:MSFT) - Benzinga
NVDA death cross signals volatility ahead for Nvidia investors - TradingView
Nvidia-backed CoreWeave plans to downsize US IPO, source says - Marketscreener.com
BofA Says Nvidia Volatility May Persist Ahead of U.S. Export Rule Implementation - Yahoo Finance
AMD is struggling against Nvidia. It could soon face a resurgent Intel as well. - MarketWatch
Nvidia’s stock now looks cheap to some analysts. So why does it keep falling? - MarketWatch
Nvidia Faces Fresh China Setback As Chip Shortages And Sanctions Disrupt Supply - Benzinga
AMD gets another downgrade on tough competition with Nvidia - The Mercury News
Jim Cramer on NVIDIA (NVDA): “They Were Remarkable” - Yahoo Finance
Nvidia reportedly in talks to buy Lepton AI - Yahoo Finance
Top Midday Stories: Tesla Shares Rise, Others Fall Post-Tariff Announcement; Nvidia-Backed CoreWeave to Cut IPO to $1.5 Billion - Marketscreener.com
Finanzdaten der Nvidia Corp-Aktie (NVDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):